Omixon Biocomputing Ltd.
Hungary HU-MF-000003018 Last updated 21 Oct 2026
- Devices
- 27
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
NanoTYPE HLA-11 Plus (24) CE Ref NT2411v3CE
NanoTYPE HLA-11 Plus (96) CE Ref NT9611v3CE
NanoTYPE 96/11 CE Ref NT9611CE
AzureSeq 4 CE qPCR Kit for 200 Reactions Ref AzureSeq 4-200 CE
NanoTYPE 24/11 CE Ref NT2411CE
NanoTYPE 4x96/11 CE Ref NT4x9611CE
NanoTYPER Ref SW6
Omixon HLA TWIN Ref SW1
AzureSeq CE qPCR Kit SARS-CoV-2 for 400 Reactions Ref AzureSeq-400 CE
AzureSeq CE qPCR Kit SARS-CoV-2 for 200 Reactions Ref AzureSeq-200 CE
EUDAMED certificates
Notified body 2797 1 certificate
- IVDR 747706 Supplemented
Quality management system EU IVDR
- Issued
- 8 Oct 2024
- Expires
- 27 May 2029
- Reason
- Add device or group
Related companies
Notified bodies
- Notified body 2797
About
Welcome to Omixon! Omixon’s mission is empowering clinical labs with NGS technologies to improve patient outcomes. Find more about our HLA Typing work...
Information
- Country
- Hungary
- Address
- 14-18., Kaposvár u., Budapest, Hungary
- Website
- www.omixon.com/
- linkedin.com/company/1099302
- [email protected]
- PRRC contact
- Linda Komporday
- EUDAMED SRN
- HU-MF-000003018